Literature DB >> 9395829

Retrospective study of ocular surface squamous neoplasia.

G A Lee1, L W Hirst.   

Abstract

BACKGROUND: Ocular surface squamous neoplasia (OSSN) encompasses the conditions of simple dysplasia to carcinoma in situ to invasive squamous cell carcinoma. It has a high rate of recurrence after treatment and the potential to metastasize. The present retrospective study was aimed at further defining the characteristics and clinical course of OSSN.
METHODS: With ethical approval, the records of all major pathology laboratories in Queensland were surveyed. Two hundred and eighty-eight cases were identified: 155 dysplasia, 71 carcinomas in situ and 62 invasive squamous cell carcinoma. The records were analysed and an attempt was made to contact and re-examine the patients.
RESULTS: Ocular surface squamous neoplasia occurs mainly in males (78.5%) with a mean age of 60.1 years (range 20-88 years). They present as irritation (40.1%) and are located usually at the limbus (87.8%). The majority of OSSN are treated by simple excision (87.5%), after which there is a high rate of recurrence (23.3%). The main predictors for recurrence include histological grade of the lesion, corneal location and larger size (> 2 mm).
CONCLUSIONS: Management of OSSN requires adequate excision and careful follow up to monitor any recurrence. As with other ultraviolet light-related conditions, preventative measures must remain the key to disease control.

Entities:  

Mesh:

Year:  1997        PMID: 9395829     DOI: 10.1111/j.1442-9071.1997.tb01514.x

Source DB:  PubMed          Journal:  Aust N Z J Ophthalmol        ISSN: 0814-9763


  30 in total

1.  Reliability of impression cytology for the diagnosis of ocular surface squamous neoplasia employing the Biopore membrane.

Authors:  D M Tole; P A McKelvie; M Daniell
Journal:  Br J Ophthalmol       Date:  2001-02       Impact factor: 4.638

2.  Squamous cell carcinoma of the conjunctiva: a series of 26 cases.

Authors:  Penelope A McKelvie; Mark Daniell; Alan McNab; Michael Loughnan; John D Santamaria
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

Review 3.  The aetiology and associations of conjunctival intraepithelial neoplasia.

Authors:  C A Kiire; B Dhillon
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

Review 4.  Updates in Ocular Surface Tumor Diagnostics.

Authors:  Afshan A Nanji; Carolina Mercado; Anat Galor; Sander Dubovy; Carol L Karp
Journal:  Int Ophthalmol Clin       Date:  2017

5.  Ocular surface squamous neoplasia in xeroderma pigmentosum: clinical spectrum and outcome.

Authors:  Noopur Gupta; Ritika Sachdev; Radhika Tandon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-12       Impact factor: 3.117

6.  Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.

Authors:  Afshan A Nanji; Christina S Moon; Anat Galor; Julia Sein; Patrick Oellers; Carol L Karp
Journal:  Ophthalmology       Date:  2014-01-09       Impact factor: 12.079

7.  Intracorneal and Intraocular Invasion of Ocular Surface Squamous Neoplasia after Intraocular Surgery: Report of Two Cases and Review of the Literature.

Authors:  Juan C Murillo; Anat Galor; Michael C Wu; Natasha K Kye; James Wong; Ibrahim O Ahmed; Madhura Joag; Nabeel Shalabi; William Lahners; Sander Dubovy; Carol L Karp
Journal:  Ocul Oncol Pathol       Date:  2016-10-21

8.  Predictors of ocular surface squamous neoplasia recurrence after excisional surgery.

Authors:  Anat Galor; Carol L Karp; Patrick Oellers; Andrew A Kao; Amany Abdelaziz; William Feuer; Sander R Dubovy
Journal:  Ophthalmology       Date:  2012-06-14       Impact factor: 12.079

9.  Conjunctival Lesions; a Histopathologic Review in Fars Province, Iran.

Authors:  Roshanak Aliakbar-Navahi; Mohammad Javad Ashraf; Nosaibe Seirfar; Samaneh Koohestani; Elham Abedi
Journal:  J Ophthalmic Vis Res       Date:  2015 Apr-Jun

10.  Multiple oncogenic viruses identified in Ocular surface squamous neoplasia in HIV-1 patients.

Authors:  Kenneth O Simbiri; Masanao Murakami; Michael Feldman; Andrew P Steenhoff; Oathokwa Nkomazana; Gregory Bisson; Erle S Robertson
Journal:  Infect Agent Cancer       Date:  2010-03-26       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.